ID

34469

Description

Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.; ODM derived from: https://clinicaltrials.gov/show/NCT02050542

Lien

https://clinicaltrials.gov/show/NCT02050542

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 11/02/2020 11/02/2020 - Christian Arras
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient from 45 to 75 years old;
Description

ID.1

Type de données

boolean

serum level of psa > 4,0 ng / ml;
Description

ID.2

Type de données

boolean

multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
Description

ID.3

Type de données

boolean

no opposition of the patient notified in the medical record
Description

ID.4

Type de données

boolean

patient member in a national insurance scheme.
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate biopsy;
Description

ID.6

Type de données

boolean

suspicious digital rectal examination;
Description

ID.7

Type de données

boolean

serum psa > 20,0 ng / ml;
Description

ID.8

Type de données

boolean

treatment with 5 alpha reductase inhibitor during the last 3 months;
Description

ID.9

Type de données

boolean

untreated urinary infection
Description

ID.10

Type de données

boolean

Similar models

Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient from 45 to 75 years old;
boolean
ID.2
Item
serum level of psa > 4,0 ng / ml;
boolean
ID.3
Item
multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
boolean
ID.4
Item
no opposition of the patient notified in the medical record
boolean
ID.5
Item
patient member in a national insurance scheme.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
previous prostate biopsy;
boolean
ID.7
Item
suspicious digital rectal examination;
boolean
ID.8
Item
serum psa > 20,0 ng / ml;
boolean
ID.9
Item
treatment with 5 alpha reductase inhibitor during the last 3 months;
boolean
ID.10
Item
untreated urinary infection
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial